nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.084	0.282	CbGbCtD
Brinzolamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0568	0.19	CbGbCtD
Brinzolamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0542	0.182	CbGbCtD
Brinzolamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0483	0.162	CbGbCtD
Brinzolamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0283	0.095	CbGbCtD
Brinzolamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0267	0.0897	CbGbCtD
Brinzolamide—CA7—trachea—chronic obstructive pulmonary disease	0.0016	0.116	CbGeAlD
Brinzolamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00141	0.102	CbGeAlD
Brinzolamide—CA1—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00125	0.0591	CbGpPWpGaD
Brinzolamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00124	0.0895	CbGeAlD
Brinzolamide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00177	CcSEcCtD
Brinzolamide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00176	CcSEcCtD
Brinzolamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00176	CcSEcCtD
Brinzolamide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00176	CcSEcCtD
Brinzolamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00175	CcSEcCtD
Brinzolamide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00175	CcSEcCtD
Brinzolamide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.0547	CbGpPWpGaD
Brinzolamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00174	CcSEcCtD
Brinzolamide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00173	CcSEcCtD
Brinzolamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00173	CcSEcCtD
Brinzolamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00173	CcSEcCtD
Brinzolamide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00173	CcSEcCtD
Brinzolamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00172	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00172	CcSEcCtD
Brinzolamide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00171	CcSEcCtD
Brinzolamide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00171	CcSEcCtD
Brinzolamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00171	CcSEcCtD
Brinzolamide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00171	CcSEcCtD
Brinzolamide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.0017	CcSEcCtD
Brinzolamide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0017	CcSEcCtD
Brinzolamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00169	CcSEcCtD
Brinzolamide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00169	CcSEcCtD
Brinzolamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00168	CcSEcCtD
Brinzolamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00168	CcSEcCtD
Brinzolamide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00168	CcSEcCtD
Brinzolamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00112	0.0806	CbGeAlD
Brinzolamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00166	CcSEcCtD
Brinzolamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00165	CcSEcCtD
Brinzolamide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00165	CcSEcCtD
Brinzolamide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00165	CcSEcCtD
Brinzolamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00163	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00163	CcSEcCtD
Brinzolamide—Cough—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00163	CcSEcCtD
Brinzolamide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00163	CcSEcCtD
Brinzolamide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00162	CcSEcCtD
Brinzolamide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00161	CcSEcCtD
Brinzolamide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Brinzolamide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Brinzolamide—Cough—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Brinzolamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00158	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00158	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00158	CcSEcCtD
Brinzolamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00157	CcSEcCtD
Brinzolamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00157	CcSEcCtD
Brinzolamide—CA12—trachea—chronic obstructive pulmonary disease	0.00104	0.0752	CbGeAlD
Brinzolamide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00156	CcSEcCtD
Brinzolamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00155	CcSEcCtD
Brinzolamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00155	CcSEcCtD
Brinzolamide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00155	CcSEcCtD
Brinzolamide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00155	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00154	CcSEcCtD
Brinzolamide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00102	0.0484	CbGpPWpGaD
Brinzolamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00154	CcSEcCtD
Brinzolamide—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00153	CcSEcCtD
Brinzolamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00152	CcSEcCtD
Brinzolamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00151	CcSEcCtD
Brinzolamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00151	CcSEcCtD
Brinzolamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000999	0.0015	CcSEcCtD
Brinzolamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000999	0.0015	CcSEcCtD
Brinzolamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000999	0.0015	CcSEcCtD
Brinzolamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000998	0.0015	CcSEcCtD
Brinzolamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000995	0.00149	CcSEcCtD
Brinzolamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000995	0.00149	CcSEcCtD
Brinzolamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00148	CcSEcCtD
Brinzolamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00148	CcSEcCtD
Brinzolamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000987	0.00148	CcSEcCtD
Brinzolamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000987	0.00148	CcSEcCtD
Brinzolamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000985	0.00148	CcSEcCtD
Brinzolamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000985	0.00148	CcSEcCtD
Brinzolamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000982	0.00147	CcSEcCtD
Brinzolamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00147	CcSEcCtD
Brinzolamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000974	0.00146	CcSEcCtD
Brinzolamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000965	0.00145	CcSEcCtD
Brinzolamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000951	0.00143	CcSEcCtD
Brinzolamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00142	CcSEcCtD
Brinzolamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00142	CcSEcCtD
Brinzolamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000943	0.00141	CcSEcCtD
Brinzolamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000939	0.00141	CcSEcCtD
Brinzolamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.0014	CcSEcCtD
Brinzolamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00093	0.0014	CcSEcCtD
Brinzolamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000926	0.00139	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000924	0.00139	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000924	0.00139	CcSEcCtD
Brinzolamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00138	CcSEcCtD
Brinzolamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00138	CcSEcCtD
Brinzolamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000912	0.00137	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000905	0.00136	CcSEcCtD
Brinzolamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000904	0.00136	CcSEcCtD
Brinzolamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000904	0.00136	CcSEcCtD
Brinzolamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000902	0.00135	CcSEcCtD
Brinzolamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000902	0.00135	CcSEcCtD
Brinzolamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00135	CcSEcCtD
Brinzolamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00134	CcSEcCtD
Brinzolamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000893	0.00134	CcSEcCtD
Brinzolamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000893	0.00134	CcSEcCtD
Brinzolamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000892	0.00134	CcSEcCtD
Brinzolamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000889	0.00133	CcSEcCtD
Brinzolamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000883	0.00132	CcSEcCtD
Brinzolamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000881	0.00132	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00131	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00131	CcSEcCtD
Brinzolamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000874	0.00131	CcSEcCtD
Brinzolamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000874	0.00131	CcSEcCtD
Brinzolamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000874	0.00131	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00131	CcSEcCtD
Brinzolamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.000872	0.063	CbGeAlD
Brinzolamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000867	0.0013	CcSEcCtD
Brinzolamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000867	0.0013	CcSEcCtD
Brinzolamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.0013	CcSEcCtD
Brinzolamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000864	0.0013	CcSEcCtD
Brinzolamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00129	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000858	0.00129	CcSEcCtD
Brinzolamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000856	0.00128	CcSEcCtD
Brinzolamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000854	0.00128	CcSEcCtD
Brinzolamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000851	0.00128	CcSEcCtD
Brinzolamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000849	0.00127	CcSEcCtD
Brinzolamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00127	CcSEcCtD
Brinzolamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000843	0.00126	CcSEcCtD
Brinzolamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00084	0.00126	CcSEcCtD
Brinzolamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000839	0.00126	CcSEcCtD
Brinzolamide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000838	0.0396	CbGpPWpGaD
Brinzolamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000837	0.00126	CcSEcCtD
Brinzolamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000836	0.00125	CcSEcCtD
Brinzolamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000836	0.00125	CcSEcCtD
Brinzolamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000835	0.00125	CcSEcCtD
Brinzolamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00125	CcSEcCtD
Brinzolamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000831	0.00125	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.00124	CcSEcCtD
Brinzolamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000826	0.00124	CcSEcCtD
Brinzolamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00123	CcSEcCtD
Brinzolamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000806	0.00121	CcSEcCtD
Brinzolamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000806	0.00121	CcSEcCtD
Brinzolamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.0012	CcSEcCtD
Brinzolamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000792	0.00119	CcSEcCtD
Brinzolamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000792	0.00119	CcSEcCtD
Brinzolamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00119	CcSEcCtD
Brinzolamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000789	0.00118	CcSEcCtD
Brinzolamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000789	0.00118	CcSEcCtD
Brinzolamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.00118	CcSEcCtD
Brinzolamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000787	0.00118	CcSEcCtD
Brinzolamide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000775	0.00116	CcSEcCtD
Brinzolamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000761	0.00114	CcSEcCtD
Brinzolamide—CA12—lung—chronic obstructive pulmonary disease	0.000748	0.054	CbGeAlD
Brinzolamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000747	0.00112	CcSEcCtD
Brinzolamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000747	0.00112	CcSEcCtD
Brinzolamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000746	0.00112	CcSEcCtD
Brinzolamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.00112	CcSEcCtD
Brinzolamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000732	0.0011	CcSEcCtD
Brinzolamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000728	0.00109	CcSEcCtD
Brinzolamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.00109	CcSEcCtD
Brinzolamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.000723	0.0522	CbGeAlD
Brinzolamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000718	0.00108	CcSEcCtD
Brinzolamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000718	0.00108	CcSEcCtD
Brinzolamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00107	CcSEcCtD
Brinzolamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00106	CcSEcCtD
Brinzolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—chronic obstructive pulmonary disease	0.000703	0.0332	CbGpPWpGaD
Brinzolamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000703	0.00105	CcSEcCtD
Brinzolamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000694	0.00104	CcSEcCtD
Brinzolamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.00104	CcSEcCtD
Brinzolamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000691	0.00104	CcSEcCtD
Brinzolamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.00103	CcSEcCtD
Brinzolamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00068	0.00102	CcSEcCtD
Brinzolamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00102	CcSEcCtD
Brinzolamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000673	0.00101	CcSEcCtD
Brinzolamide—CA5B—lung—chronic obstructive pulmonary disease	0.000671	0.0484	CbGeAlD
Brinzolamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00101	CcSEcCtD
Brinzolamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00101	CcSEcCtD
Brinzolamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000657	0.000985	CcSEcCtD
Brinzolamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.000983	CcSEcCtD
Brinzolamide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000646	0.00097	CcSEcCtD
Brinzolamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.000967	CcSEcCtD
Brinzolamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000645	0.000967	CcSEcCtD
Brinzolamide—CA4—trachea—chronic obstructive pulmonary disease	0.000644	0.0465	CbGeAlD
Brinzolamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000639	0.000959	CcSEcCtD
Brinzolamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000639	0.000959	CcSEcCtD
Brinzolamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000639	0.000958	CcSEcCtD
Brinzolamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000639	0.000958	CcSEcCtD
Brinzolamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.000636	0.046	CbGeAlD
Brinzolamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000635	0.000953	CcSEcCtD
Brinzolamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.000953	CcSEcCtD
Brinzolamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.000951	CcSEcCtD
Brinzolamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000633	0.00095	CcSEcCtD
Brinzolamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000632	0.000947	CcSEcCtD
Brinzolamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000626	0.000939	CcSEcCtD
Brinzolamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000626	0.000939	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000624	0.000937	CcSEcCtD
Brinzolamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000624	0.000936	CcSEcCtD
Brinzolamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000622	0.000933	CcSEcCtD
Brinzolamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.000913	CcSEcCtD
Brinzolamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000607	0.00091	CcSEcCtD
Brinzolamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000605	0.000907	CcSEcCtD
Brinzolamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.000906	CcSEcCtD
Brinzolamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.000905	CcSEcCtD
Brinzolamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000602	0.000904	CcSEcCtD
Brinzolamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.000904	CcSEcCtD
Brinzolamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.0009	CcSEcCtD
Brinzolamide—CA2—bronchus—chronic obstructive pulmonary disease	0.000595	0.043	CbGeAlD
Brinzolamide—CA1—lung—chronic obstructive pulmonary disease	0.000592	0.0428	CbGeAlD
Brinzolamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00059	0.000885	CcSEcCtD
Brinzolamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000582	0.042	CbGeAlD
Brinzolamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000581	0.000872	CcSEcCtD
Brinzolamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000858	CcSEcCtD
Brinzolamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.000853	CcSEcCtD
Brinzolamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000566	0.000849	CcSEcCtD
Brinzolamide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000552	0.000828	CcSEcCtD
Brinzolamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000536	0.000804	CcSEcCtD
Brinzolamide—CA2—trachea—chronic obstructive pulmonary disease	0.000534	0.0386	CbGeAlD
Brinzolamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000787	CcSEcCtD
Brinzolamide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00051	0.000765	CcSEcCtD
Brinzolamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000761	CcSEcCtD
Brinzolamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000502	0.000753	CcSEcCtD
Brinzolamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000497	0.000745	CcSEcCtD
Brinzolamide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000496	0.000745	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000493	0.00074	CcSEcCtD
Brinzolamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000738	CcSEcCtD
Brinzolamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000489	0.000734	CcSEcCtD
Brinzolamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000489	0.000734	CcSEcCtD
Brinzolamide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000482	0.0228	CbGpPWpGaD
Brinzolamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00047	0.000705	CcSEcCtD
Brinzolamide—CA4—lung—chronic obstructive pulmonary disease	0.000463	0.0334	CbGeAlD
Brinzolamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000691	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000681	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.000679	CcSEcCtD
Brinzolamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000449	0.000674	CcSEcCtD
Brinzolamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000661	CcSEcCtD
Brinzolamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000439	0.000659	CcSEcCtD
Brinzolamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.000654	CcSEcCtD
Brinzolamide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000425	0.0201	CbGpPWpGaD
Brinzolamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000633	CcSEcCtD
Brinzolamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000624	CcSEcCtD
Brinzolamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000624	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00062	CcSEcCtD
Brinzolamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000617	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.000607	CcSEcCtD
Brinzolamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000595	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000391	0.000587	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000584	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000581	CcSEcCtD
Brinzolamide—CA2—lung—chronic obstructive pulmonary disease	0.000384	0.0277	CbGeAlD
Brinzolamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000545	CcSEcCtD
Brinzolamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.000545	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000541	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000358	0.000538	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000527	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00052	CcSEcCtD
Brinzolamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.000519	CcSEcCtD
Brinzolamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.000519	CcSEcCtD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000345	0.0163	CbGpPWpGaD
Brinzolamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000344	0.000516	CcSEcCtD
Brinzolamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000516	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000493	CcSEcCtD
Brinzolamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000489	CcSEcCtD
Brinzolamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000326	0.0154	CbGpPWpGaD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000326	0.0154	CbGpPWpGaD
Brinzolamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000476	CcSEcCtD
Brinzolamide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.000311	0.0147	CbGpPWpGaD
Brinzolamide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000302	0.0143	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000441	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00043	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000424	CcSEcCtD
Brinzolamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00041	CcSEcCtD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000265	0.0125	CbGpPWpGaD
Brinzolamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000396	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000381	CcSEcCtD
Brinzolamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000253	0.0119	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000253	0.0119	CbGpPWpGaD
Brinzolamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000377	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000377	CcSEcCtD
Brinzolamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000375	CcSEcCtD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000247	0.0116	CbGpPWpGaD
Brinzolamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000356	CcSEcCtD
Brinzolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.0104	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	0.00021	0.00992	CbGpPWpGaD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000208	0.00981	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000205	0.00966	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000205	0.00966	CbGpPWpGaD
Brinzolamide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00944	CbGpPWpGaD
Brinzolamide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00904	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000191	0.00902	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000191	0.00902	CbGpPWpGaD
Brinzolamide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.00867	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.000177	0.00836	CbGpPWpGaD
Brinzolamide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00834	CbGpPWpGaD
Brinzolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00753	CbGpPWpGaD
Brinzolamide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000153	0.00723	CbGpPWpGaD
Brinzolamide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00686	CbGpPWpGaD
Brinzolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000143	0.00675	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000141	0.00666	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000139	0.00657	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.0064	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.0064	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000135	0.00639	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000135	0.00639	CbGpPWpGaD
Brinzolamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.0063	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000132	0.00623	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GC—chronic obstructive pulmonary disease	0.000132	0.00623	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00013	0.00613	CbGpPWpGaD
Brinzolamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00606	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000127	0.00598	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000127	0.00598	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000126	0.00594	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000123	0.00581	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000123	0.00581	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000123	0.00579	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000123	0.00579	CbGpPWpGaD
Brinzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00567	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000117	0.00554	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000116	0.00545	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000114	0.0054	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000114	0.0054	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000114	0.00539	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.000114	0.00539	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000106	0.00501	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.43e-05	0.00445	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.35e-05	0.00441	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	9.1e-05	0.00429	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.96e-05	0.00423	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	8.72e-05	0.00412	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.59e-05	0.00406	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.46e-05	0.00399	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	8.36e-05	0.00395	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.11e-05	0.00383	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.8e-05	0.00368	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.77e-05	0.00367	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.63e-05	0.0036	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.56e-05	0.00357	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.53e-05	0.00355	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.39e-05	0.00349	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	7.35e-05	0.00347	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	7.31e-05	0.00345	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.2e-05	0.0034	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.2e-05	0.0034	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	7.12e-05	0.00336	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.12e-05	0.00336	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.85e-05	0.00324	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.83e-05	0.00323	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.73e-05	0.00318	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.73e-05	0.00318	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	6.67e-05	0.00315	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	6.65e-05	0.00314	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	6.65e-05	0.00314	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.5e-05	0.00307	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	6.5e-05	0.00307	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.23e-05	0.00294	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.18e-05	0.00292	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	6.16e-05	0.00291	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.14e-05	0.0029	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	6.07e-05	0.00286	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	6.07e-05	0.00286	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.00283	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.00283	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	5.8e-05	0.00274	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	5.62e-05	0.00265	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.00264	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.00264	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.54e-05	0.00262	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.47e-05	0.00258	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.18e-05	0.00244	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.12e-05	0.00242	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.05e-05	0.00239	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.99e-05	0.00236	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.99e-05	0.00236	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.97e-05	0.00235	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.92e-05	0.00233	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.92e-05	0.00233	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.91e-05	0.00232	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.76e-05	0.00225	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	4.71e-05	0.00223	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.00222	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.71e-05	0.00222	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.0022	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.0022	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.6e-05	0.00217	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.6e-05	0.00217	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.00217	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.00217	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.57e-05	0.00216	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.51e-05	0.00213	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.49e-05	0.00212	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.48e-05	0.00212	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-05	0.00211	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.00205	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.00205	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.32e-05	0.00204	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.3e-05	0.00203	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.00202	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.00202	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.26e-05	0.00201	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.00195	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.12e-05	0.00195	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.00192	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.00192	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.02e-05	0.0019	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.97e-05	0.00187	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.97e-05	0.00187	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.96e-05	0.00187	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.95e-05	0.00187	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.91e-05	0.00184	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.00179	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.00178	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.62e-05	0.00171	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	3.56e-05	0.00168	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.44e-05	0.00163	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.4e-05	0.0016	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.34e-05	0.00158	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.3e-05	0.00156	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.00155	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	3.26e-05	0.00154	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.26e-05	0.00154	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.24e-05	0.00153	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.00149	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.16e-05	0.00149	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.12e-05	0.00147	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-05	0.00143	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.03e-05	0.00143	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.00142	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	2.96e-05	0.0014	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	2.96e-05	0.0014	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.00137	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-05	0.00137	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.88e-05	0.00136	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.00134	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.00134	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.78e-05	0.00131	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-05	0.0013	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-05	0.0013	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.0013	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.74e-05	0.0013	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.00129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.00128	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-05	0.00125	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-05	0.00125	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.56e-05	0.00121	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	2.56e-05	0.00121	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.52e-05	0.00119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.00117	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	2.45e-05	0.00116	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.00114	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.00113	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00111	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	2.04e-05	0.000963	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	1.96e-05	0.000923	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.95e-05	0.000921	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.92e-05	0.000907	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	1.87e-05	0.000885	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.87e-05	0.000883	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.79e-05	0.000847	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	1.65e-05	0.000778	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.58e-05	0.000744	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.000601	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.24e-05	0.000584	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000543	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.76e-06	0.000319	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.68e-06	0.000315	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.1e-06	0.000288	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.62e-06	0.000265	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.69e-06	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.62e-06	0.000218	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.31e-06	0.000203	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-06	0.000193	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.77e-06	0.000131	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-06	0.000125	CbGpPWpGaD
